nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—Chemical phlebitis—Teniposide—lymphatic system cancer	0.176	0.176	CcSEcCtD
Carboprost Tromethamine—Endometritis—Mitoxantrone—lymphatic system cancer	0.0922	0.0922	CcSEcCtD
Carboprost Tromethamine—Septic shock—Vincristine—lymphatic system cancer	0.0226	0.0226	CcSEcCtD
Carboprost Tromethamine—Vasospasm—Carmustine—lymphatic system cancer	0.0209	0.0209	CcSEcCtD
Carboprost Tromethamine—Hypoxia—Fludarabine—lymphatic system cancer	0.0176	0.0176	CcSEcCtD
Carboprost Tromethamine—Respiratory distress—Fludarabine—lymphatic system cancer	0.0176	0.0176	CcSEcCtD
Carboprost Tromethamine—Extravasation—Teniposide—lymphatic system cancer	0.0146	0.0146	CcSEcCtD
Carboprost Tromethamine—Epigastric pain—Mitoxantrone—lymphatic system cancer	0.0137	0.0137	CcSEcCtD
Carboprost Tromethamine—Respiratory failure—Fludarabine—lymphatic system cancer	0.0114	0.0114	CcSEcCtD
Carboprost Tromethamine—Respiratory distress—Vincristine—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Carboprost Tromethamine—Phlebitis—Teniposide—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Carboprost Tromethamine—Phlebitis—Fludarabine—lymphatic system cancer	0.0094	0.0094	CcSEcCtD
Carboprost Tromethamine—Extravasation—Bleomycin—lymphatic system cancer	0.00938	0.00938	CcSEcCtD
Carboprost Tromethamine—Sleep disorder—Fludarabine—lymphatic system cancer	0.00936	0.00936	CcSEcCtD
Carboprost Tromethamine—Injection site pain—Carmustine—lymphatic system cancer	0.00875	0.00875	CcSEcCtD
Carboprost Tromethamine—Extravasation—Carmustine—lymphatic system cancer	0.00818	0.00818	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Mechlorethamine—lymphatic system cancer	0.00806	0.00806	CcSEcCtD
Carboprost Tromethamine—Wheezing—Bleomycin—lymphatic system cancer	0.00794	0.00794	CcSEcCtD
Carboprost Tromethamine—Extravasation—Vincristine—lymphatic system cancer	0.00781	0.00781	CcSEcCtD
Carboprost Tromethamine—Extravasation—Mitoxantrone—lymphatic system cancer	0.00761	0.00761	CcSEcCtD
Carboprost Tromethamine—Respiratory failure—Vincristine—lymphatic system cancer	0.00694	0.00694	CcSEcCtD
Carboprost Tromethamine—Phlebitis—Bleomycin—lymphatic system cancer	0.00689	0.00689	CcSEcCtD
Carboprost Tromethamine—Sweating increased—Fludarabine—lymphatic system cancer	0.00682	0.00682	CcSEcCtD
Carboprost Tromethamine—Vertigo—Mechlorethamine—lymphatic system cancer	0.00676	0.00676	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Fludarabine—lymphatic system cancer	0.00651	0.00651	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00614	0.00614	CcSEcCtD
Carboprost Tromethamine—Infection—Mechlorethamine—lymphatic system cancer	0.0061	0.0061	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Fludarabine—lymphatic system cancer	0.00607	0.00607	CcSEcCtD
Carboprost Tromethamine—Phlebitis—Carmustine—lymphatic system cancer	0.00602	0.00602	CcSEcCtD
Carboprost Tromethamine—Flushing—Teniposide—lymphatic system cancer	0.00592	0.00592	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Fludarabine—lymphatic system cancer	0.00589	0.00589	CcSEcCtD
Carboprost Tromethamine—Eye pain—Carmustine—lymphatic system cancer	0.00574	0.00574	CcSEcCtD
Carboprost Tromethamine—Chills—Teniposide—lymphatic system cancer	0.00572	0.00572	CcSEcCtD
Carboprost Tromethamine—Phlebitis—Mitoxantrone—lymphatic system cancer	0.00559	0.00559	CcSEcCtD
Carboprost Tromethamine—Hypoxia—Methotrexate—lymphatic system cancer	0.00521	0.00521	CcSEcCtD
Carboprost Tromethamine—Chills—Fludarabine—lymphatic system cancer	0.00503	0.00503	CcSEcCtD
Carboprost Tromethamine—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.00498	0.00498	CcSEcCtD
Carboprost Tromethamine—Hypertension—Teniposide—lymphatic system cancer	0.00479	0.00479	CcSEcCtD
Carboprost Tromethamine—Haematemesis—Methotrexate—lymphatic system cancer	0.00476	0.00476	CcSEcCtD
Carboprost Tromethamine—Chest pain—Teniposide—lymphatic system cancer	0.00472	0.00472	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00453	0.00453	CcSEcCtD
Carboprost Tromethamine—Infection—Teniposide—lymphatic system cancer	0.0045	0.0045	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Teniposide—lymphatic system cancer	0.00442	0.00442	CcSEcCtD
Carboprost Tromethamine—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.0044	0.0044	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00438	0.00438	CcSEcCtD
Carboprost Tromethamine—Cough—Fludarabine—lymphatic system cancer	0.00426	0.00426	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Carboprost Tromethamine—Myalgia—Fludarabine—lymphatic system cancer	0.00415	0.00415	CcSEcCtD
Carboprost Tromethamine—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00406	0.00406	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Teniposide—lymphatic system cancer	0.00404	0.00404	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00398	0.00398	CcSEcCtD
Carboprost Tromethamine—Infection—Fludarabine—lymphatic system cancer	0.00395	0.00395	CcSEcCtD
Carboprost Tromethamine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Carmustine—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Carboprost Tromethamine—Rash—Mechlorethamine—lymphatic system cancer	0.00387	0.00387	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.00387	0.00387	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00387	0.00387	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00385	0.00385	CcSEcCtD
Carboprost Tromethamine—Flushing—Bleomycin—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Carboprost Tromethamine—Extravasation—Methotrexate—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Carboprost Tromethamine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Carboprost Tromethamine—Chills—Bleomycin—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Carboprost Tromethamine—Nausea—Mechlorethamine—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00363	0.00363	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.00361	0.00361	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Teniposide—lymphatic system cancer	0.00358	0.00358	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Fludarabine—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Fludarabine—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Carboprost Tromethamine—Pain—Fludarabine—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Carboprost Tromethamine—Respiratory failure—Methotrexate—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Teniposide—lymphatic system cancer	0.00334	0.00334	CcSEcCtD
Carboprost Tromethamine—Flushing—Carmustine—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Carboprost Tromethamine—Asthenia—Teniposide—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Fludarabine—lymphatic system cancer	0.00315	0.00315	CcSEcCtD
Carboprost Tromethamine—Cough—Bleomycin—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Teniposide—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Carboprost Tromethamine—Myalgia—Bleomycin—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Carboprost Tromethamine—Chest pain—Bleomycin—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Carboprost Tromethamine—Back pain—Carmustine—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Carboprost Tromethamine—Chills—Mitoxantrone—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Carboprost Tromethamine—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Carmustine—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00293	0.00293	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Carboprost Tromethamine—Infection—Bleomycin—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Carboprost Tromethamine—Back pain—Vincristine—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Carboprost Tromethamine—Vomiting—Teniposide—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Carboprost Tromethamine—Asthenia—Fludarabine—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Carboprost Tromethamine—Rash—Teniposide—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Teniposide—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Carboprost Tromethamine—Headache—Teniposide—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Carboprost Tromethamine—Back pain—Mitoxantrone—lymphatic system cancer	0.00281	0.00281	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Carboprost Tromethamine—Hypertension—Carmustine—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Carboprost Tromethamine—Nausea—Teniposide—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Carboprost Tromethamine—Vertigo—Vincristine—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Carboprost Tromethamine—Chest pain—Carmustine—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Carboprost Tromethamine—Myalgia—Carmustine—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Carboprost Tromethamine—Anxiety—Carmustine—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Bleomycin—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Bleomycin—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Carboprost Tromethamine—Hypertension—Vincristine—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Carboprost Tromethamine—Myalgia—Vincristine—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Carboprost Tromethamine—Cough—Mitoxantrone—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Carboprost Tromethamine—Infection—Carmustine—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Carboprost Tromethamine—Vomiting—Fludarabine—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Carboprost Tromethamine—Rash—Fludarabine—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Fludarabine—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Carboprost Tromethamine—Hypertension—Mitoxantrone—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Carboprost Tromethamine—Pain—Bleomycin—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Carboprost Tromethamine—Headache—Fludarabine—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Carmustine—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Carboprost Tromethamine—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Carboprost Tromethamine—Myalgia—Mitoxantrone—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Carboprost Tromethamine—Chest pain—Mitoxantrone—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Carboprost Tromethamine—Anxiety—Mitoxantrone—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Carboprost Tromethamine—Lethargy—Methotrexate—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Carboprost Tromethamine—Infection—Vincristine—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Carboprost Tromethamine—Nausea—Fludarabine—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Carboprost Tromethamine—Infection—Mitoxantrone—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Carboprost Tromethamine—Shock—Mitoxantrone—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Bleomycin—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Carmustine—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Carmustine—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Carboprost Tromethamine—Somnolence—Carmustine—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Vincristine—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Carboprost Tromethamine—Pain—Carmustine—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Carboprost Tromethamine—Somnolence—Mitoxantrone—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Carboprost Tromethamine—Asthenia—Bleomycin—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Carboprost Tromethamine—Pain—Vincristine—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Carboprost Tromethamine—Asthma—Methotrexate—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Carboprost Tromethamine—Pain—Mitoxantrone—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Carmustine—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Vincristine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Carmustine—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Carboprost Tromethamine—Vomiting—Bleomycin—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Carboprost Tromethamine—Drowsiness—Methotrexate—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Carboprost Tromethamine—Rash—Bleomycin—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Bleomycin—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Carboprost Tromethamine—Asthenia—Carmustine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Vincristine—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Methotrexate—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Carboprost Tromethamine—Asthenia—Vincristine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Carmustine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Carboprost Tromethamine—Nausea—Bleomycin—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Carboprost Tromethamine—Asthenia—Mitoxantrone—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Carboprost Tromethamine—Dizziness—Carmustine—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Vincristine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Carboprost Tromethamine—Vomiting—Carmustine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Carboprost Tromethamine—Dizziness—Vincristine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Carboprost Tromethamine—Rash—Carmustine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Carmustine—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Carboprost Tromethamine—Headache—Carmustine—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Methotrexate—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Carboprost Tromethamine—Vomiting—Vincristine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Carboprost Tromethamine—Rash—Vincristine—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Vincristine—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Carboprost Tromethamine—Headache—Vincristine—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Carboprost Tromethamine—Nausea—Carmustine—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Carboprost Tromethamine—Vomiting—Mitoxantrone—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Carboprost Tromethamine—Rash—Mitoxantrone—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Carboprost Tromethamine—Chills—Methotrexate—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Carboprost Tromethamine—Headache—Mitoxantrone—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Carboprost Tromethamine—Nausea—Vincristine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Carboprost Tromethamine—Nausea—Mitoxantrone—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Carboprost Tromethamine—Back pain—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Methotrexate—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Carboprost Tromethamine—Vertigo—Methotrexate—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Carboprost Tromethamine—Cough—Methotrexate—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Carboprost Tromethamine—Chest pain—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Carboprost Tromethamine—Myalgia—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Carboprost Tromethamine—Infection—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Methotrexate—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Carboprost Tromethamine—Somnolence—Methotrexate—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Carboprost Tromethamine—Pain—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000933	0.000933	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000869	0.000869	CcSEcCtD
Carboprost Tromethamine—Asthenia—Methotrexate—lymphatic system cancer	0.000847	0.000847	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000807	0.000807	CcSEcCtD
Carboprost Tromethamine—Dizziness—Methotrexate—lymphatic system cancer	0.00078	0.00078	CcSEcCtD
Carboprost Tromethamine—Vomiting—Methotrexate—lymphatic system cancer	0.00075	0.00075	CcSEcCtD
Carboprost Tromethamine—Rash—Methotrexate—lymphatic system cancer	0.000744	0.000744	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Methotrexate—lymphatic system cancer	0.000743	0.000743	CcSEcCtD
Carboprost Tromethamine—Headache—Methotrexate—lymphatic system cancer	0.000739	0.000739	CcSEcCtD
Carboprost Tromethamine—Nausea—Methotrexate—lymphatic system cancer	0.000701	0.000701	CcSEcCtD
